ENDOPIN

N/A

Report date: 2025/07/18 14:26:39
NME

Base Information

Drug NameENDOPIN
Drug Alias NameBTB-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-2b adrenergic receptor inhibitors
TargetsAlpha-2b adrenergic receptor
Therapy Area/IndicationsCancer PainPain, PostoperativePruritus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKyoto University
China Registration ClassN/A

Develop Information

Active CompaniesBTB Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCancer PainPain, PostoperativePruritus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A